Bright Minds Biosciences Inc • DRUG

Capital at risk.

About Bright Minds Biosciences Inc
Ticker
info
DRUG
Trading on
info
NASDAQ
ISIN
info
CA10919W1086
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Ian McDonald
Headquarters
info
19 Vestry Street, New York, NY, United States, 10013
Employees
info
0
Website
info
https://brightmindsbio.com
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.
Metrics
BasicAdvanced
Market cap
info
$236M
P/E ratio
info
-
EPS
info
-$0.14
Dividend Yield
info
0.00%
Beta
info
1.02
Forward P/E ratio
info
0
EBIDTA
info
-
Ex dividend date
info
-
Price & volume
Market cap
info
$236M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
5.66
Earnings
EPS
info
-$0.14
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
-$0.18
EBITDA
info
-
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.02
52-week High
info
$79.02
52-week Low
info
$0.93
50-day moving average
info
$35.26
200-day moving average
info
$24.97
Short ratio
info
2.57
Short %
info
2.08%
Management effectiveness
ROE (TTM)
info
3.35%
ROA (TTM)
info
4.93%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
7M
Float
info
2.5M
Insiders %
info
22.55%
Institutions %
info
78.92%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.10
-
-
Q1 • 24Beat
$0.04
-
-
Q2 • 24Beat
-$0.13
-$0.60
79.12%
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-0.7M
∞%
Q3 • 24
$0M
$0M
∞%
Q4 • 24
NaN%
106.62%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$6.1M
$0.6M
9.31%
Q3 • 24
$58.4M
$0.6M
0.98%
Q4 • 24
856.63%
0.59%
89.49%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.5M
-
$-0M
$-0.5M
Q3 • 24
$-1.5M
-
$52M
$-1.5M
Q4 • 24
222.64%
-
221,014.82%
222.64%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Bright Minds Biosciences Inc share?
Collapse

Bright Minds Biosciences Inc shares are currently traded for undefined per share.

How many shares does Bright Minds Biosciences Inc have?
Collapse

Bright Minds Biosciences Inc currently has 7M shares.

Does Bright Minds Biosciences Inc pay dividends?
Collapse

No, Bright Minds Biosciences Inc doesn't pay dividends.

What is Bright Minds Biosciences Inc 52 week high?
Collapse

Bright Minds Biosciences Inc 52 week high is $79.02.

What is Bright Minds Biosciences Inc 52 week low?
Collapse

Bright Minds Biosciences Inc 52 week low is $0.93.

What is the 200-day moving average of Bright Minds Biosciences Inc?
Collapse

Bright Minds Biosciences Inc 200-day moving average is $24.97.

Who is Bright Minds Biosciences Inc CEO?
Collapse

The CEO of Bright Minds Biosciences Inc is Ian McDonald.

How many employees Bright Minds Biosciences Inc has?
Collapse

Bright Minds Biosciences Inc has 0 employees.

What is the market cap of Bright Minds Biosciences Inc?
Collapse

The market cap of Bright Minds Biosciences Inc is $236M.

What is the P/E of Bright Minds Biosciences Inc?
Collapse

The current P/E of Bright Minds Biosciences Inc is null.

What is the EPS of Bright Minds Biosciences Inc?
Collapse

The EPS of Bright Minds Biosciences Inc is -$0.14.

What is the PEG Ratio of Bright Minds Biosciences Inc?
Collapse

The PEG Ratio of Bright Minds Biosciences Inc is null.